Echottrack: A Prospective Echocardiography-Study On Participants With Heart Failure That Fit The Age-Group For Transthyretin-Amyloidosis To Track The Frequency Of Echo-Red- Flags.

Echottrack: A Prospective Echocardiography-Study On Participants With Heart Failure That Fit The Age-Group For Transthyretin-Amyloidosis To Track The Frequency Of Echo-Red- Flags. - ECHOTTRACK

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033692

Enrollment

1000

Registered

2024-04-10

Start date

2024-04-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E85

Interventions

Group 1: Participants matching eligibility criteria. All participants are one cohort. No drug under study. In the study a one-time transthoracic-echocardiography assessment is taking place, which is

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: -Signed, written informed consent -Signs and symptoms of chronic heart failure

Exclusion criteria

Exclusion criteria: -Confirmed diagnosis of ATTR-CM (transthyretin amyloid cardiomyopathy) -Chronic heart failure with NYHA IV classification -Participants that are not able to sign the informed consent by themselves. -Participants who are employees of Pfizer or the study site and their family members.

Design outcomes

Primary

Measure	Time frame
Frequency of echocardiography-parameters typical for cardiac amyloidosis	—

Secondary

Measure	Time frame
Correlation between demographic and anamnestic data with echocardiography-parameters	—

Countries

Germany

Contacts

Public ContactUdo Sechtem

Cardiologicum Stuttgart MVZ GbR

udo.sechtem@rbk.de07 11 / 2 18 40 60

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026